Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Aspira Pathlab and Diagnostics Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Aspira Pathlab and Diagnostics Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Change in Directorate

    23 May 2026, 8:02PM The Board approved the appointment of Mr. Vaibhav Odhekar as an Additional Executive Director for 5 years
  • Aspira Pathlab & Dia - Appointment of Company Secretary and Compliance Officer

    23 May 2026, 7:54PM The disclosure regarding of Mrs. Neetu Maurya as a Company Secretary of the company with effect from 24.05.2026 was inadvertently filed under change i
  • Aspira Pathlab & Dia posts Q4 net loss of Rs 0.69 cr

    23 May 2026, 7:50PM The company reported standalone net loss during the quarter stood at Rs 0.69 crore compared to net profit of Rs 0.72 crore in the previous year quarte
  • Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Change in Management Control

    23 May 2026, 7:47PM Appointment of Mrs. Neetu Maurya as Company Secretary of the Company With Effect From 24.05.2026
  • Aspira Pathlab & Dia - Appointment Of M/S. Vishal J Bhanushali & Associates, Practicing Chartered Accountant (Firm Registrati

    23 May 2026, 7:44PM Appointment of M/s. Vishal J Bhanushali & Associates, as an Internal Auditor for F.Y. 2026-27 of the Company
  • Aspira Pathlab & Dia - Integrated Financial Results As On March 31, 2026

    23 May 2026, 7:21PM Integrated Financial Results as on March 31, 2026
  • Aspira Pathlab & Dia - Board Meeting Outcome For Outcome Of The Board Meeting Dated May 23, 2026

    23 May 2026, 6:58PM Board Meeting outcome for Dated May 23, 2026
  • Aspira Pathlab & Dia - Board Meeting Outcome for Outcome Of The Board Meeting Dated May 23, 2026

    23 May 2026, 6:55PM Outcome of the Board Meeting dated May 23, 2026
  • Aspira Pathlab & Dia - Board Meeting Intimation for Approval Of Audited Standalone Financial Results Of The Company Along W

    18 May 2026, 8:16PM Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 ,inter alia, to
  • Aspira Pathlab & Dia - Post-Offer Advertisement

    18 May 2026, 5:36PM Aftertrade Broking Pvt Ltd (\Manager to the Offer\) has submitted to BSE a copy of Post-Offer Advertisement for the attention of the Equity Shareholde
  • Aspira Pathlab & Dia has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    18 Apr 2026, 11:00AM As of March 2026, 18.39% is owned by Indian Promoters and 81.61% by Public. <p align=justify> Top four Promoters holding highest number of shares of A
  • Aspira Pathlab & Dia - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

    15 Apr 2026, 1:00PM <b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'> <tr> <td><b>Sr
  • Aspira Pathlab & Dia - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    15 Apr 2026, 12:52PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Aspira Pathlab & Dia - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    14 Apr 2026, 1:11PM Compliance Certificate in accordance with Regulation 74(5) of SEBI (DP) Regulations, 2018 For quarter ended 31 March 2026
  • Aspira Pathlab & Dia - Updates on Open Offer

    13 Apr 2026, 4:51PM Aftertrade Broking Pvt Ltd (\Manager to the Offer\) has submitted to BSE a copy of Pre-Offer Advertisement and Corrignendum to the Detailed Public Sta
  • Aspira Pathlab & Dia - Updates on Open Offer

    10 Apr 2026, 7:39PM Aftertrade Broking Pvt Ltd (\Manager to the Offer\) has submitted to BSE a copy of Recommendation of the Independent Director Committee ('IDC') in rel
  • Aspira Pathlab & Dia - Letter of Offer

    7 Apr 2026, 3:44PM Aftertrade Broking Pvt Ltd (\Manager to the Offer\) has submitted to BSE a copy of Letter of Offer to the Public Shareholders of Aspira Pathlab & Diag
  • Aspira Pathlab & Dia - Intimation of Identified Date

    25 Mar 2026, 12:01PM Aftertrade Broking Pvt Ltd (\Manager to the Offer\) has informed BSE regarding Intimation of Identified Date for the Proposed Open Offer of Aspira Pat

Key fundamentals

Evaluate the intrinsic value of Aspira Pathlab and Diagnostics Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 13.5822 13.4227 11.2205 13.7122 13.6482
Liabilities 13.5822 13.4227 11.2205 13.7122 13.6482
Equity 10.293 10.293 10.293 10.293 10.293
Gross Profit 1.4632 3.5249 -1.1868 1.5932 6.3731
Net Profit 0.0513 2.0726 -2.6722 -0.0887 4.4594
Cash From Operating Activities 1.4536 1.877 1.053 -0.0121 2.031
NPM(%) 0.2 9.42 -20.23 -0.61 22.81
Revenue 24.982 21.999 13.2049 14.4569 19.5419
Expenses 23.5188 18.4741 14.3917 12.8637 13.1688
ROE(%) 0.39 16.11 -20.77 -0.68 34.67

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Aspira Pathlab and Diagnostics Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 700.00 -3.04 0.00 70.20 -26.19 0.70
Lotus Eye Hospital and Institute Ltd 124.15 12.51 4154.00 255.79 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 17.42 -0.57 0.00 531.11 -39.50 0.00
Astec Lifesciences Ltd 755.80 -3.05 0.00 241.22 -363.14 0.00

Company Info

Aspira Pathlab & Diagnostics Ltd. Was incorporated as 03td July in the year 1973 in the name of 'industrial Gas & Steel Products (India) Ltd.' It has changed its name to 'Utkal Soap Products Ltd.' on 4th February, 1980. USPL with the main object of dealing in gases Products & Steel Products, Subsequent to change of name of the Company, it has changed its object in 1980 to manufacture laundry soaps for Hindustan Lever Limited, having its factory at Sambalput - Orissa. the Company has stopped Manufacturing production since November, 2004 as the job work for Hindustan Lever Limited was not renewed because of additional duties levied by the Government, it has became unviable proposal & the Company has disposed off all its assets in 2005. The employees have been paid off their dues as per settlement with the Labour union, Since 2005.The Company has changed its object clause on 10th August, 2016 & Ventured into diagnostic centers laboratories etc, & stated generating income from December, 2016 onwards. The Company changed its name to 'Aspira Parthlab & Diagnostics Ltd.' on 16th November, 2016. 2025-The Company Acquire 100% of stake in Aspira DNA Diagnostics Gujarat LLP.

Aspira Pathlab & Diagnostics Ltd. Was incorporated as 03td July in the year 1973 in the name of 'industrial Gas & Steel Products (India) Ltd.' It has changed its name to 'Utkal Soap Products Ltd.' on 4th February, 1980. USPL with the main object of dealing in gases Products & Steel Products, Subsequent to change of name of the Company, it has changed its object in 1980 to manufacture laundry soaps for Hindustan Lever Limited, having its factory at Sambalput - Orissa. the Company has stopped Manufacturing production since November, 2004 as the job work for Hindustan Lever Limited was not renewed because of additional duties levied by the Government, it has became unviable proposal & the Company has disposed off all its assets in 2005. The employees have been paid off their dues as per settlement with the Labour union, Since 2005.The Company has changed its object clause on 10th August, 2016 & Ventured into diagnostic centers laboratories etc, & stated generating income from December, 2016 onwards. The Company changed its name to 'Aspira Parthlab & Diagnostics Ltd.' on 16th November, 2016. 2025-The Company Acquire 100% of stake in Aspira DNA Diagnostics Gujarat LLP.

Read More

Parent Organisation

Aspira Pathlab & Diagnostics Ltd.

Founded

03/07/1973

Managing Director

Dr.Pankaj J Shah

NSE Symbol

FAQ

The current price of Aspira Pathlab and Diagnostics Ltd is

The 52-week high for Aspira Pathlab and Diagnostics Ltd is

The market capitalization of Aspira Pathlab and Diagnostics Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Aspira Pathlab and Diagnostics Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Aspira Pathlab and Diagnostics Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Aspira Pathlab and Diagnostics Ltd shares.

The CEO of Aspira Pathlab and Diagnostics Ltd is Dr.Pankaj J Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT